These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1313638)

  • 1. Maintenance itraconazole for visceral leishmaniasis in HIV infection.
    Lafeuillade A; Chaffanjon P; Delbeke E; Quilichini R
    Am J Med; 1992 Apr; 92(4):449. PubMed ID: 1313638
    [No Abstract]   [Full Text] [Related]  

  • 2. Visceral leishmaniasis and HIV infection: unusual presentation with pleuropulmonary involvement, and effect of secondary prophylaxis.
    Matheron S; Cabié A; Parquin F; Mayaud C; Roux P; Antoine M; Chougnet C; Coulaud JP
    AIDS; 1992 Feb; 6(2):238-40. PubMed ID: 1558727
    [No Abstract]   [Full Text] [Related]  

  • 3. Itraconazole versus ketaconazole in the treatment of oral and oesophageal candidosis in patients infected with HIV.
    Smith DE; Midgley J; Allan M; Connolly GM; Gazzard BG
    AIDS; 1991 Nov; 5(11):1367-71. PubMed ID: 1662959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Visceral leishmaniasis with partial response to ketoconazole in a patient with positive antibodies to the human immunodeficiency virus].
    Andreo JA; Vivancos F; Serrano P; Soriano J
    Med Clin (Barc); 1991 Oct; 97(12):476-7. PubMed ID: 1753824
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnosis and treatment of oral candidosis.
    Lewis MA; Samaranyake LP; Lamey PJ
    J Oral Maxillofac Surg; 1991 Sep; 49(9):996-1002. PubMed ID: 1653314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disseminated histoplasmosis in an AIDS patient treated with itraconazole.
    Kell PD; Smith DE; Barton SE; Midgley J; Samarasinghe PL; Gazzard BG
    Genitourin Med; 1991 Aug; 67(4):342-4. PubMed ID: 1655628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Itraconazole as maintenance treatment for cryptococcal meningitis in the acquired immune deficiency syndrome.
    de Gans J; Eeftinck Schattenkerk JK; van Ketel RJ
    Br Med J (Clin Res Ed); 1988 Jan; 296(6618):339. PubMed ID: 2830934
    [No Abstract]   [Full Text] [Related]  

  • 8. [Visceral leishmaniasis and HIV infection].
    Pieltain Alvarez-Arenas R; Audibert Mena L; Pérez Mochales J; Tewfick M; Ortiz Alonso FJ; de Miguel Novoa MP
    Rev Clin Esp; 1991 Jul; 189(3):150. PubMed ID: 1947391
    [No Abstract]   [Full Text] [Related]  

  • 9. Penicillium marneffei infection in patients infected with human immunodeficiency virus.
    Supparatpinyo K; Chiewchanvit S; Hirunsri P; Uthammachai C; Nelson KE; Sirisanthana T
    Clin Infect Dis; 1992 Apr; 14(4):871-4. PubMed ID: 1315586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 infection, visceral leishmaniasis, Koch's chest and tuberculous meningitis in the same patient--a case report.
    Pandey K; Sinha PK; Das VN; Kumar N; Hassan SM; Verma N; Lal CS; Bimal S; Das P; Bhattacharya SK
    Ann Trop Med Parasitol; 2005 Dec; 99(8):807-11. PubMed ID: 16297295
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of pentamidine for the treatment of cutaneous leishmaniasis in Colombia.
    Soto-Mancipe J; Grogl M; Berman JD
    Clin Infect Dis; 1993 Mar; 16(3):417-25. PubMed ID: 8384011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylaxis of fungal infections with itraconazole in immunocompromised cancer patients.
    Mühldorfer SM; König HJ
    Mycoses; 1990 Jun; 33(6):291-5. PubMed ID: 2175392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Visceral leishmaniasis in human immunodeficiency virus disease.
    Montalban C
    J Clin Pathol; 1991 Nov; 44(11):965-6. PubMed ID: 1752995
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral Leishmaniasis treated with antimonials/paromomycin followed by itraconazole/miltefosine after standard therapy failures in a human immunodeficiency virus-infected patient.
    Barragán P; López-Velez R; Olmo M; Podzamczer D
    Am J Trop Med Hyg; 2010 Jul; 83(1):10-2. PubMed ID: 20595469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mycoses as opportunistic infections in AIDS patients].
    Viviani MA
    Med Klin (Munich); 1991 Dec; 86 Suppl 1():19-22. PubMed ID: 1663202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Atypical presentation and fatal evolution of visceral leishmaniasis in a patient infected with HIV].
    Muńiz Grijalvo O; Losada Vińau J; Rizo Valero A; Miranda Guisado ML
    Rev Clin Esp; 1991 Jul; 189(3):151-2. PubMed ID: 1947393
    [No Abstract]   [Full Text] [Related]  

  • 17. [Visceral leishmaniasis and HIV infection: 2 new cases].
    Gonzalo Hernández C; Arazo Garces P; Alvarez Casasnovas G; Alonso Casas F; Jorda Rebol P; Aguirre Errasti JM
    An Med Interna; 1991 Apr; 8(4):208-9. PubMed ID: 1912185
    [No Abstract]   [Full Text] [Related]  

  • 18. Visceral leishmaniasis: another HIV-associated opportunistic infection? Report of eight cases and review of the literature.
    Altés J; Salas A; Riera M; Udina M; Galmés A; Balanzat J; Ballesteros A; Buades J; Salvá F; Villalonga C
    AIDS; 1991 Feb; 5(2):201-7. PubMed ID: 2031693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Visceral leishmaniasis and immunosuppression].
    Lortholary O; Christiaens D; Mechali D; Babinet P
    Ann Med Interne (Paris); 1991; 142(3):215-7. PubMed ID: 1854134
    [No Abstract]   [Full Text] [Related]  

  • 20. Diffuse cutaneous dissemination of visceral leishmaniasis during human immunodeficiency virus (HIV) infection, despite negligible immunodeficiency: repeated failure of liposomal amphotericin B administration, followed by successful long-term pentamidine and paromomycin administration.
    Manfredi R; Marinacci G; Calza L; Passarini B
    Int J Antimicrob Agents; 2008 Jun; 31(6):590-2. PubMed ID: 18456464
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.